AtheroMed EASEs into PAD catheter trial

Twitter icon
Facebook icon
LinkedIn icon
e-mail icon
Google icon

AtheroMed has begun enrolling patients into the EASE (Endovascular Atherectomy Safety and Effectiveness) trial that will evaluate the safety and effectiveness of the Phoenix Atherectomy catheter, a device used to treat peripheral arterial disease (PAD).

The Phoenix catheter cuts, captures and conveys arterial plaque into an external bag, and has a deflectable tip that is used to treat a range of blood vessel sizes with a single insertion, according to the Menlo Park, Calif.-based company.

Currently, the Phoenix catheter is approved for investigational use only in the U.S., but has gained a CE mark for use in the European Union.